TFX 10-Q Quarterly Report April 1, 2012

TFX 10-Q Quarter ended April 1, 2012

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

TELEFLEX INC

10-Ks and 10-Qs

10-Q	Quarter ended Sept. 28, 2025
10-Q	Quarter ended June 29, 2025
10-Q	Quarter ended March 30, 2025
10-K	Fiscal year ended Dec. 31, 2024
10-Q	Quarter ended Sept. 29, 2024
10-Q	Quarter ended June 30, 2024
10-Q	Quarter ended March 31, 2024
10-K	Fiscal year ended Dec. 31, 2023
10-Q	Quarter ended Oct. 1, 2023
10-Q	Quarter ended July 2, 2023
10-Q	Quarter ended April 2, 2023
10-K	Fiscal year ended Dec. 31, 2022
10-Q	Quarter ended Sept. 25, 2022
10-Q	Quarter ended June 26, 2022
10-Q	Quarter ended March 27, 2022
10-K	Fiscal year ended Dec. 31, 2021
10-Q	Quarter ended Sept. 26, 2021
10-Q	Quarter ended June 27, 2021
10-Q	Quarter ended March 28, 2021
10-K	Fiscal year ended Dec. 31, 2020
10-Q	Quarter ended Sept. 27, 2020
10-Q	Quarter ended June 28, 2020
10-Q	Quarter ended March 29, 2020
10-K	Fiscal year ended Dec. 31, 2019
10-Q	Quarter ended Sept. 29, 2019
10-Q	Quarter ended June 30, 2019
10-Q	Quarter ended March 31, 2019
10-K	Fiscal year ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended July 1, 2018
10-Q	Quarter ended April 1, 2018
10-K	Fiscal year ended Dec. 31, 2017
10-Q	Quarter ended Oct. 1, 2017
10-Q	Quarter ended July 2, 2017
10-Q	Quarter ended April 2, 2017
10-K	Fiscal year ended Dec. 31, 2016
10-Q	Quarter ended Sept. 25, 2016
10-Q	Quarter ended June 26, 2016
10-Q	Quarter ended March 27, 2016
10-K	Fiscal year ended Dec. 31, 2015
10-Q	Quarter ended Sept. 27, 2015
10-Q	Quarter ended June 28, 2015
10-Q	Quarter ended March 29, 2015
10-K	Fiscal year ended Dec. 31, 2014
10-Q	Quarter ended Sept. 28, 2014
10-Q	Quarter ended June 29, 2014
10-Q	Quarter ended March 30, 2014
10-K	Fiscal year ended Dec. 31, 2013
10-Q	Quarter ended Sept. 29, 2013
10-Q	Quarter ended June 30, 2013
10-Q	Quarter ended March 31, 2013
10-K	Fiscal year ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended July 1, 2012
10-Q	Quarter ended April 1, 2012
10-K	Fiscal year ended Dec. 31, 2011
10-Q	Quarter ended Sept. 25, 2011
10-Q	Quarter ended June 26, 2011
10-Q	Quarter ended March 27, 2011
10-K	Fiscal year ended Dec. 31, 2010
10-Q	Quarter ended Sept. 26, 2010
10-Q	Quarter ended June 27, 2010
10-Q	Quarter ended March 28, 2010
10-K	Fiscal year ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on May 9, 2025
DEF 14A	Filed on March 28, 2025
DEF 14A	Filed on May 3, 2024
DEF 14A	Filed on April 1, 2024
DEF 14A	Filed on March 31, 2023
DEF 14A	Filed on April 29, 2022
DEF 14A	Filed on March 30, 2022
DEF 14A	Filed on March 26, 2021
DEF 14A	Filed on March 27, 2020
DEF 14A	Filed on March 29, 2019
DEF 14A	Filed on March 30, 2018
DEF 14A	Filed on March 31, 2017
DEF 14A	Filed on March 24, 2016
DEF 14A	Filed on March 17, 2015
DEF 14A	Filed on March 28, 2014
DEF 14A	Filed on March 29, 2013
DEF 14A	Filed on March 30, 2012
DEF 14A	Filed on March 25, 2011
DEF 14A	Filed on March 26, 2010

10-Q 1 d332618d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 1, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission file number 1-5353

TELEFLEX INCORPORATED

(Exact name of registrant as specified in its charter)


Delaware		23-1147939
(State or other jurisdiction of incorporation or organization)		(I.R.S. employer identification no.)

155 South Limerick Road, Limerick, Pennsylvania		19468
(Address of principal executive offices)		(Zip Code)

(610) 948-5100

(Registrant’s telephone number, including area code)

(None)

(Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

The registrant had 40,812,152 shares of common stock, $1.00 par value, outstanding as of April 20, 2012.

TELEFLEX INCORPORATED

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED APRIL 1, 2012

TABLE OF CONTENTS


		Page
PART I — FINANCIAL INFORMATION

Item 1:	Financial Statements (Unaudited):
	Condensed Consolidated Statements of Income for the three months ended April 1, 2012 and March 27, 2011		2
	Condensed Consolidated Statements of Comprehensive Income for the three months ended April 1, 2012 and March 27, 2011		3
	Condensed Consolidated Balance Sheets as of April 1, 2012 and December 31, 2011		4
	Condensed Consolidated Statements of Cash Flows for the three months ended April 1, 2012 and March 27, 2011		5
	Condensed Consolidated Statements of Changes in Equity for the three months ended April 1, 2012 and March 27, 2011		6
	Notes to Condensed Consolidated Financial Statements		7
Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations		25
Item 3:	Quantitative and Qualitative Disclosures About Market Risk		31
Item 4:	Controls and Procedures		31

PART II — OTHER INFORMATION

Item 1:	Legal Proceedings		32
Item 1A:	Risk Factors		32
Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds		32
Item 3:	Defaults Upon Senior Securities		32
Item 5:	Other Information		32
Item 6:	Exhibits		33

SIGNATURES			34

PART I — FINANCIAL INFORMATION

Item 1.

Financial Statements

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars and shares in thousands, except per share)

Net revenues	$	387,757		$	354,004
Cost of goods sold		201,922			189,500

Gross profit		185,835			164,504
Selling, general and administrative expenses		113,378			103,206
Research and development expenses		11,562			11,038
Goodwill impairment		332,128			—
Restructuring and other impairment charges		(838	)		595

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		(270,395	)		49,665
Interest expense		18,211			16,146
Interest income		(478	)		(105	)
Loss on extinguishments of debt		—			14,597

Income (loss) from continuing operations before taxes		(288,128	)		19,027
Taxes (benefit) on income from continuing operations		(4,019	)		4,915

Income (loss) from continuing operations		(284,109	)		14,112

Operating income from discontinued operations (including gain on disposal of $56,773 in 2011)		946			63,756
Taxes (benefit) on income from discontinued operations		345			(326	)

Income from discontinued operations		601			64,082

Net income (loss)		(283,508	)		78,194
Less: Income from continuing operations attributable to noncontrolling interest		227			223
Income from discontinued operations attributable to noncontrolling interest		—			159

Net income (loss) attributable to common shareholders	$	(283,735	)	$	77,812


Earnings per share available to common shareholders:
Basic:
Income (loss) from continuing operations	$	(6.97	)	$	0.35
Income from discontinued operations		0.01			1.59

Net income (loss)	$	(6.96	)	$	1.94


Diluted:
Income (loss) from continuing operations	$	(6.97	)	$	0.34
Income from discontinued operations		0.01			1.58

Net income (loss)	$	(6.96	)	$	1.92


Dividends per share	$	0.34		$	0.34

Weighted average common shares outstanding:
Basic		40,769			40,057
Diluted		40,769			40,424

Amounts attributable to common shareholders:
Income (loss) from continuing operations, net of tax	$	(284,336	)	$	13,889
Income from discontinued operations, net of tax		601			63,923

Net income (loss)	$	(283,735	)	$	77,812

The accompanying notes are an integral part of the condensed consolidated financial statements.

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars and shares in thousands, except per share)

Net income (loss)	$	(283,508	)	$	78,194
Other comprehensive income, net of tax:
Foreign currency:
Foreign currency translation continuing operations adjustments, net of tax ($4,213 – 2012; $2,348 – 2011)		30,683			48,224
Foreign currency translation discontinued operations adjustments		—			2,072
Foreign currency translation divestiture of Marine		—			(33,424	)

Foreign currency translation, net of tax		30,683			16,872


Pension and Other Postretirement Benefits Plans:
Prior service cost recognized in net periodic cost, net of tax ($(2) – 2012; $(2) – 2011)		(3	)		(4	)
Transition obligation recognized in net periodic cost, net of tax ($9 – 2012; $10 – 2011)		15			17
Unamortized gain arising during the period, net of tax ($2,883 – 2011)		—			4,682
Net loss recognized in net periodic cost, net of tax ($605 – 2012; $400 – 2011)		1,105			704
Discontinued operations, net of tax ($(14) – 2011)		—			(37	)
Divestiture of Marine, net of tax ($4,612 – 2011)		—			8,427
Foreign currency translation, net of tax ($(50) – 2012; $(182) – 2011)		(139	)		(483	)

Pension and other postretirement benefits plans adjustment, net of tax		978			13,306


Derivatives qualifying as hedges:
Unrealized gain (loss) on derivatives arising during the period, net of tax ($321 – 2012; $231 – 2011)		693			(161	)
Reclassification adjustment on derivatives included in net income, net of tax ($1,087 – 2012; $1,211 – 2011)		1,767			1,925
Discontinued operations, net of tax ($81 – 2011)		—			142

Derivatives qualifying as hedges, net of tax		2,460			1,906


Other comprehensive income, net of tax		34,121			32,084


Comprehensive income (loss)		(249,387	)		110,278

Less: comprehensive income attributable to noncontrolling interest		305			376


Comprehensive income (loss) attributable to common shareholders	$	(249,692	)	$	109,902

The accompanying notes are an integral part of the condensed consolidated financial statements.

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


	April 1, 2012		December 31, 2011
	(Dollars in thousands)

ASSETS

Current assets
Cash and cash equivalents	$	590,921	$	584,088
Accounts receivable, net		310,926		286,226
Inventories, net		298,971		298,775
Prepaid expenses and other current assets		36,939		33,405
Prepaid taxes		37,677		28,846
Deferred tax assets		39,312		41,014
Assets held for sale		8,026		7,902

Total current assets		1,322,772		1,280,256
Property, plant and equipment, net		263,415		251,912
Goodwill		1,119,696		1,438,542
Intangible assets, net		871,711		879,787
Investments in affiliates		1,847		2,008
Deferred tax assets		292		278
Other assets		70,153		71,320

Total assets	$	3,649,886	$	3,924,103


LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	4,700	$	4,986
Accounts payable		62,330		67,092
Accrued expenses		84,509		78,160
Payroll and benefit-related liabilities		58,367		64,386
Derivative liabilities		1,496		633
Accrued interest		11,618		10,960
Income taxes payable		27,761		21,084
Current liability for uncertain tax positions		23,484		22,656
Deferred tax liabilities		1,081		1,050

Total current liabilities		275,346		271,007
Long-term borrowings		957,360		954,809
Deferred tax liabilities		412,656		420,833
Pension and postretirement benefit liabilities		187,064		194,984
Noncurrent liability for uncertain tax positions		63,037		61,688
Other liabilities		32,577		37,999

Total liabilities		1,928,040		1,941,320
Commitments and contingencies
Total common shareholders’ equity		1,719,346		1,980,588
Noncontrolling interest		2,500		2,195

Total equity		1,721,846		1,982,783

Total liabilities and equity	$	3,649,886	$	3,924,103

The accompanying notes are an integral part of the condensed consolidated financial statements.

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in thousands)
Cash Flows from Operating Activities of Continuing Operations:
Net income (loss)	$	(283,508	)	$	78,194
Adjustments to reconcile net income to net cash provided by operating activities:
Income from discontinued operations		(601	)		(64,082	)
Depreciation expense		8,919			10,328
Amortization expense of intangible assets		10,880			11,013
Amortization expense of deferred financing costs and debt discount		3,530			3,300
Loss on extinguishments of debt		—			14,597
Stock-based compensation		1,719			(1,091	)
Goodwill impairment		332,128			—
Deferred income taxes, net		(12,624	)		(1,745	)
Other		(3,877	)		717
Changes in operating assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable		(18,762	)		(23,142	)
Inventories		2,245			(10,599	)
Prepaid expenses and other current assets		(1,768	)		(489	)
Accounts payable and accrued expenses		(9,652	)		(7,373	)
Income taxes receivable and payable, net		(1,896	)		(2,368	)

Net cash provided by operating activities from continuing operations		26,733			7,260


Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		(15,029	)		(5,891	)
Proceeds from sales of businesses and assets, net of cash sold		—			101,600
Payments for businesses and intangibles acquired, net of cash acquired		—			(30,570	)

Net cash (used in) provided by investing activities from continuing operations		(15,029	)		65,139


Cash Flows from Financing Activities of Continuing Operations:
Proceeds from long-term borrowings		—			265,000
Repayment of long-term borrowings		—			(330,800	)
Decrease in notes payable and current borrowings		(286	)		—
Proceeds from stock compensation plans		1,594			6,764
Dividends		(13,866	)		(13,614	)
Debt extinguishment, issuance and amendment fees		—			(14,838	)

Net cash used in financing activities from continuing operations		(12,558	)		(87,488	)


Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities		(2,595	)		1,693
Net cash used in investing activities		—			(802	)

Net cash (used in) provided by discontinued operations		(2,595	)		891


Effect of exchange rate changes on cash and cash equivalents		10,282			8,044

Net increase (decrease) in cash and cash equivalents		6,833			(6,154	)
Cash and cash equivalents at the beginning of the period		584,088			208,452

Cash and cash equivalents at the end of the period	$	590,921		$	202,298

The accompanying notes are an integral part of the condensed consolidated financial statements.

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(Unaudited)


											Accumulated
					Additional						Other			Treasury
	Common Stock				Paid in			Retained			Comprehensive			Stock						Noncontrolling			Total
	Shares		Dollars		Capital			Earnings			Income			Shares			Dollars			Interest			Equity
	(Dollars and shares in thousands, except per share)
Balance at December 31, 2010		42,245	$	42,245	$	349,156		$	1,578,913		$	(51,880	)		2,250		$	(135,058	)	$	3,902		$	1,787,278
Net income									77,812												382			78,194
Cash dividends ($0.34 per share)									(13,614	)														(13,614	)

Comprehensive income												32,090									(6	)		32,084
Shares issued under compensation plans		155		155		1,512									(54	)		3,255						4,922
Deferred compensation						(39	)								(4	)		163						124


Balance at March 27, 2011		42,400	$	42,400	$	350,629		$	1,643,111		$	(19,790	)		2,192		$	(131,640	)	$	4,278		$	1,888,988


											Accumulated
					Additional						Other			Treasury
	Common Stock				Paid in			Retained			Comprehensive			Stock						Noncontrolling		Total
	Shares		Dollars		Capital			Earnings			Income			Shares			Dollars			Interest		Equity
	(Dollars and shares in thousands, except per share)
Balance at December 31, 2011		42,923	$	42,923	$	380,965		$	1,847,106		$	(159,353	)		2,183		$	(131,053	)	$	2,195	$	1,982,783
Net income (loss)									(283,735	)											227		(283,508	)
Cash dividends ($0.34 per share)									(13,866	)													(13,866	)

Comprehensive income												34,043									78		34,121
Shares issued under compensation plans		33		33		46									(35	)		2,131					2,210
Deferred compensation						(10	)								(4	)		116					106


Balance at April 1, 2012		42,956	$	42,956	$	381,001		$	1,549,505		$	(125,310	)		2,144		$	(128,806	)	$	2,500	$	1,721,846

The accompanying notes are an integral part of the condensed consolidated financial statements.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 — Basis of presentation

We prepared the accompanying unaudited condensed consolidated financial statements of Teleflex Incorporated on the same basis as our annual consolidated financial statements.

In the opinion of management, our financial statements reflect all adjustments, which are of a normal recurring nature, necessary for a fair presentation of financial statements for interim periods in accordance with U.S. generally accepted accounting principles (GAAP) and with Rule 10-01 of SEC Regulation S-X, which sets forth the instructions for financial statements included in Form 10-Q. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of our financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

In accordance with applicable accounting standards, the accompanying condensed consolidated financial statements do not include all of the information and footnote disclosures that are required to be included in our annual consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but, as permitted by Rule 10-01 of SEC Regulation S-X, does not include all disclosures required by GAAP for complete financial statements. Accordingly, our quarterly condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2011.

Certain reclassifications of prior year information have been made to conform to the current year’s presentation. As discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, in the first quarter of 2012, the Company changed its segment reporting from a single reportable segment to four reportable segments. Three of the four reportable segments are geographically based: North America, EMEA (representing the Company’s operations in Europe, the Middle East and Africa) and AJLA (representing Asian and Latin American operations); and the fourth is comprised of the Company’s Original Equipment Manufacturer and Development Services (“OEM”) businesses. See Note 13 for a discussion of the Company’s segments. In addition, in the first quarter of 2012, the Company changed the number of its reporting units. In 2011, the Company had six reporting units comprised of North America, EMEA, OEM and three reporting units in the AJLA segment. In 2012, the Company changed North America from a single reporting unit to five reporting units comprised of Vascular, Anesthesia/Respiratory, Cardiac, Surgical and Specialty. As a result of the change in the reporting unit structure in North America the Company was required to conduct a goodwill impairment test of each of the North American reporting units and determined that the goodwill of three of the reporting units was impaired. As a result, the Company recorded a goodwill impairment charge in the first quarter of 2012 of $332 million. See Note 4 for a discussion of the goodwill impairment.

As used in this report, the terms “we,” “us,” “our,” “Teleflex” and the “Company” mean Teleflex Incorporated and its subsidiaries, unless the context indicates otherwise. The results of operations for the periods reported are not necessarily indicative of those that may be expected for a full year.

Note 2 — New accounting standards

The Company adopted the following new accounting standards as of January 1, 2012, the first day of its 2012 fiscal year:

Amendment to Fair Value Measurement: In May 2011, the FASB revised the fair value measurement and disclosure requirements so that the requirements under GAAP and International Financial Reporting Standards (“IFRS”) are the same. The guidance clarifies the FASB’s intent about the application of existing fair value measurements and requires enhanced disclosures, most significantly related to unobservable inputs used in a fair value measurement that is categorized within Level 3 of the fair value hierarchy. The guidance became effective prospectively during interim and annual periods beginning after December 15, 2011.

Amendment to Comprehensive Income: In June 2011, the FASB amended guidance relating to the presentation requirements of comprehensive income within an entity’s financial statements. Under the guidance, an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income in a single continuous statement or in two separate but consecutive statements. The amended guidance eliminates the previously available option of presenting the components of other comprehensive income as part of the statement of changes in equity. In addition, an entity is required to present adjustments on the face of the financial statements for items that are reclassified from other comprehensive income to net income in the statement where the components of net income and the components of other comprehensive income are presented. The amendment became effective for fiscal years beginning after December 15, 2011 and is applied retrospectively, with the exception of the requirement to present reclassification adjustments from other comprehensive income to net income on the face of the financial statements, which has been deferred pending further deliberation by the FASB.

Note 3 — Restructuring and other impairment charges

The amounts recognized in restructuring and other impairment charges for the three months ended April 1, 2012 and March 27, 2011 consisted of the following:


	Three Months Ended April 1, 2012			Three Months Ended March 27, 2011
	(Dollars in thousands)
2012 restructuring charges	$	605		$	—
2011 restructuring program		488			—
2007 Arrow integration program		(1,931	)		595

Restructuring and other impairment charges	$	(838	)	$	595

2012 Restructuring Charges

During the first quarter of 2012, the Company incurred restructuring charges of $0.6 million related to the termination of certain distributor agreements in Europe.

2011 Restructuring Program

During 2011, the Company initiated a restructuring program at four facilities to consolidate operations and reduce costs. In connection with this program, during the first quarter of 2012, the Company recorded restructuring charges of $0.5 million, including $0.3 million for employee termination benefits for workforce consolidations and $0.2 million for facility closure costs in connection with the program. During the remainder of 2012, the Company expects to incur additional contract termination costs of approximately $2.7 million when it has completely exited a leased facility, approximately $0.9 million for facility closure costs related to other facilities, and $0.5 million for other costs in connection with the program. All of the employee termination benefits, facility closure costs and other costs will be paid in 2012. The payment of the lease contract termination costs will continue until 2015.

2007 Arrow Integration Program

In connection with the Company’s acquisition of Arrow International, Inc. (“Arrow”), the Company implemented a program in 2007 to integrate Arrow’s businesses into the Company’s other businesses. The aspects of this program that affect Teleflex employees and facilities (such aspects being referred to as the “2007 Arrow integration program”) are charged to earnings and classified as restructuring and impairment charges. The following table provides information relating to the charges associated with the 2007 Arrow integration program that were included in restructuring and other impairment charges in the condensed consolidated statements of income for the periods presented:


	Three Months Ended April 1, 2012			Three Months Ended March 27, 2011
	(Dollars in thousands)
Termination benefits	$	—		$	7
Facility closure costs		92			150
Contract termination costs		(2,023	)		438

	$	(1,931	)	$	595

No impairment charges were recognized during the three month periods ended April 1, 2012 and March 27, 2011.

The following table provides information relating to changes in the accrued liability associated with the 2007 Arrow integration program during the three months ended April 1, 2012:


	Balance at December 31, 2011		Subsequent Accruals			Payments			Translation		Balance at April 1, 2012
	(Dollars in thousands)
Termination benefits	$	320	$	—		$	(3	)	$	8	$	325
Facility closure costs		—		92			(92	)		—		—
Contract termination costs		2,133		(2,023	)		(30	)		167		247
Other restructuring costs		21		—			—			1		22

	$	2,474	$	(1,931	)	$	(125	)	$	176	$	594

The reduction in accrual from contract termination costs relates to a revised estimate for the settlement of a dispute involving the termination of a European distributor agreement that was established in connection with the acquisition of Arrow in 2007.

As of April 1, 2012, the Company expects future restructuring expenses associated with the 2007 Arrow integration program, if any, to be nominal.

Note 4 — Impairment of goodwill

As we disclosed in our Form 10-K for the year ended December 31, 2011, we have changed our internal business unit reporting structure and related internal financial reporting effective January 1, 2012 and changed from six reporting units to ten reporting units. The change included converting our current North America business, which is one of the four operating segments, from one reporting unit into five reporting units. As a result, we allocated the assets and liabilities of the North America segment to the new reporting units based on the operating activities of the new reporting units, and then allocated goodwill among the reporting units using a relative fair value approach as required by ASC 350. The fair value of each reporting unit was determined by a weighted combination of (i) estimation of the discounted cash flows of each of the reporting units based on projected earnings in the future (the income approach) and (ii) analysis of sales of similar assets in actual transactions (the market approach).

Following this allocation, we were required to perform goodwill impairment tests on these new reporting units in the first quarter of 2012. As a result of these tests, we determined that three of the reporting units in the North America operating segment were impaired, and we recorded goodwill impairment charges of $220 million in the Vascular reporting unit, $107 million in the Anesthesia/Respiratory reporting unit and $5 million in the Cardiac reporting unit in the first quarter of 2012.

Note 5 — Inventories

Inventories as of April 1, 2012 and December 31, 2011 consisted of the following:


	April 1, 2012			December 31, 2011
	(Dollars in thousands)
Raw materials	$	88,770		$	87,621
Work-in-process		47,939			45,486
Finished goods		194,934			198,587

		331,643			331,694
Less: Inventory reserve		(32,672	)		(32,919	)

Inventories	$	298,971		$	298,775

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 6 — Goodwill and other intangible assets

In the first quarter of 2012, the Company has changed its reporting structure to four reportable segments, three of which are geographically-based and one of which is comprised of the Company’s OEM business. See Note 13, “Business segment information” for additional information on the Company’s new reporting structure.

The following table provides information relating to changes in the carrying amount of goodwill, by reporting segment, for the three months ended April 1, 2012:


	North America Segment			EMEA Segment			AJLA Segment		OEM Segment		Total
	(Dollars in thousands)
Balance as of December 31, 2011
Goodwill	$	973,517		$	283,362		$	153,487	$	28,176	$	1,438,542
Accumulated impairment losses		—			—			—		—		—

		973,517			283,362			153,487		28,176		1,438,542

Goodwill impairment charges		(332,128	)		—			—		—		(332,128	)
Translation adjustment		16			8,441			4,825		—		13,282
Transfer of goodwill		679			(679	)		—		—		—

Balance as of April 1, 2012
Goodwill		974,212			291,124			158,312		28,176		1,451,824
Accumulated impairment losses		(332,128	)		—			—		—		(332,128	)

	$	642,084		$	291,124		$	158,312	$	28,176	$	1,119,696

See Note 4 for discussion on the goodwill impairment charges.

The following table provides information, as of April 1, 2012 and December 31, 2011, regarding the gross carrying amount of, and accumulated amortization relating to, intangible assets:


	Gross Carrying Amount				Accumulated Amortization
	April 1, 2012		December 31, 2011		April 1, 2012			December 31, 2011
	(Dollars in thousands)
Customer lists	$	539,013	$	537,094	$	(123,923	)	$	(117,505	)
Intellectual property		221,803		221,171		(90,284	)		(85,402	)
Distribution rights		16,798		16,669		(13,736	)		(13,484	)
Trade names		323,314		322,404		(1,274	)		(1,160	)

	$	1,100,928	$	1,097,338	$	(229,217	)	$	(217,551	)

Amortization expense related to intangible assets was approximately $10.9 million and $11.0 million for the three months ended April 1, 2012 and March 27, 2011, respectively. Estimated annual amortization expense for the remainder of 2012 and the next four succeeding fiscal years is as follows (dollars in thousands):


2012	$	32,500
2013		41,700
2014		37,700
2015		31,500
2016		31,500

Note 7 — Financial instruments

The Company uses derivative instruments for risk management purposes. Forward rate contracts are used to manage foreign currency transaction exposure. These derivative instruments are designated as cash flow hedges and are recorded on the balance sheet at fair market value. The effective portion of the gains or losses on derivatives is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivatives representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. See Note 8, “Fair value measurement” for additional information.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following table presents the location and fair values of derivative instruments designated as hedging instruments in the condensed consolidated balance sheet as of April 1, 2012 and December 31, 2011:


	April 1, 2012 Fair Value		December 31, 2011 Fair Value
	(Dollars in thousands)
Asset derivatives:
Foreign exchange contracts:
Other assets – current	$	1,432	$	204

Total asset derivatives	$	1,432	$	204


Liability derivatives:
Foreign exchange contracts:
Derivative liabilities – current	$	1,496	$	633

Total liability derivatives	$	1,496	$	633

The following table provides information as to the gains and losses attributable to derivatives in cash flow hedging relationships that were reported in other comprehensive income (“OCI”), and the location and amount of gains and losses attributable to such derivatives that were reclassified from accumulated other comprehensive income (“AOCI”) in the condensed consolidated statement of income for the three months ended April 1, 2012 and March 27, 2011:


	After Tax Gain/(Loss) Recognized in OCI
	April 1, 2012		March 27, 2011
	(Dollars in thousands)
Interest rate contracts	$	2,386	$	1,657
Foreign exchange contracts		74		249

Total	$	2,460	$	1,906


	Pre-Tax (Gain)/Loss Reclassified from AOCI into Income
	April 1, 2012			March 27, 2011
	(Dollars in thousands)
Interest rate contracts:
Interest expense	$	3,751		$	3,720
Foreign exchange contracts
Cost of goods sold		(897	)		(584	)
Income from discontinued operations		—			(435	)

Total	$	2,854		$	2,701

For the three months ended April 1, 2012 and March 27, 2011, there was no ineffectiveness related to the Company’s derivatives.

In 2011, the Company terminated its interest rate swap covering a notional amount of $350 million designated as a hedge against the variability of the cash flows in the interest payments under the term loan. At April 1, 2012, the Company had $4.6 million, net of tax, recorded in AOCI associated with this interest rate swap, which will be amortized as interest expense over the remaining life of the original term of the hedged obligation, which expires in September 2012.

Based on interest rates and exchange rates at April 1, 2012, approximately $4.8 million of unrealized losses, net of tax, within AOCI are expected to be reclassified from AOCI during the next twelve months. However, the actual amount reclassified from AOCI could vary due to future changes in exchange rates.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 8 — Fair value measurement

For a description of the fair value hierarchy, see Note 10 to the Company’s 2011 consolidated financial statements included in its annual report on Form 10-K for the year ended December 31, 2011.

The following tables provide information regarding the financial assets and liabilities carried at fair value measured on a recurring basis as of April 1, 2012 and March 27, 2011:


	Total carrying value at April 1, 2012		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(Dollars in thousands)
Cash and cash equivalents	$	10,001	$	10,001	$	—	$	—
Investments in marketable securities		4,654		4,654		—		—
Derivative assets		1,432		—		1,432		—
Derivative liabilities		1,496		—		1,496		—
Contingent consideration liabilities		9,018		—		—		9,018


	Total carrying value at March 27, 2011		Quoted prices in active markets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
	(Dollars in thousands)
Bonds foreign government	$	7,575	$	7,575	$	—	$	—
Investments in marketable securities		4,269		4,269		—		—
Derivative assets		901		—		901		—
Derivative liabilities		21,732		—		21,732		—
Contingent consideration liabilities		9,400		—		—		9,400

The following table provides information regarding changes in Level 3 financial liabilities during the periods ended April 1, 2012 and March 27, 2011:


	Contingent consideration
	2012			2011
	(Dollars in thousands)
Beginning balance	$	9,676		$	—
Initial estimate of contingent consideration		—			15,400
Payment		—			(6,000	)
Revaluations		(658	)		—

Ending balance	$	9,018		$	9,400

The carrying amount of long-term debt reported in the condensed consolidated balance sheet as of April 1, 2012 is $957.4 million. Using a discounted cash flow technique that incorporates a market interest yield curve with adjustments for duration, optionality, and risk profile, the Company has determined the fair value of its debt to be $1,110.7 million at April 1, 2012. The Company’s implied credit rating is a factor in determining the market interest yield curve.

During the first quarter of 2012, the Company recorded a goodwill impairment charge based on Level 3 inputs. See note 4 for a discussion of the goodwill impairment.

Valuation Techniques

The Company’s cash and cash equivalents valued based upon Level 1 inputs are comprised of overnight investments in money market funds. The funds invest in obligations of the U.S. Treasury, including Treasury bills, bonds and notes. The funds seek to maintain a net asset value of $1.00 per share. The remainder of the Company’s cash and cash equivalents at April 1, 2012 is held in bank deposits.

The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to pay benefits under certain deferred compensation plans and other compensatory arrangements. The investment assets of the trust are valued using quoted market prices.

The Company’s financial assets valued based upon Level 2 inputs are comprised of foreign currency forward contracts. The Company’s financial liabilities valued based upon Level 2 inputs are comprised of an interest rate swap contract and foreign currency forward contracts. The Company uses forward rate contracts to manage currency transaction exposure and interest rate swaps to manage exposure to interest rate changes. The fair value of the foreign currency forward exchange contracts represents the amount required to enter into offsetting contracts with similar remaining maturities based on quoted market prices. The fair value of the

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

interest rate swap contract is developed from market-based inputs under the income approach using cash flows discounted at relevant market interest rates. The Company has taken into account the creditworthiness of the counterparties in measuring fair value. The decrease in the Company’s derivative liabilities in 2012 is due to the termination of an interest rate swap agreement. See Note 7, “Financial instruments” for additional information.

The Company’s financial liabilities valued based upon Level 3 inputs are comprised of contingent consideration pertaining to the VasoNova acquisition. The fair value of the contingent consideration is determined using a weighted probability of potential payment scenarios discounted at rates reflective of the Company’s credit rating and expected return on the VasoNova business. The assumptions used to develop the estimated amount recognized for the contingent consideration arrangement are updated each reporting period. As of April 1, 2012, the Company has recorded approximately $8.9 million of contingent consideration in other current liabilities. The Company expects to pay a portion of this amount in the second quarter of 2012 and the remainder in the first quarter of 2013.

Note 9 — Changes in shareholders’ equity

In 2007, the Company’s Board of Directors authorized the repurchase of up to $300 million of outstanding Company common stock. Repurchases of Company stock under the Board authorization may be made from time to time in the open market and may include privately-negotiated transactions as market conditions warrant and subject to regulatory considerations. The stock repurchase program has no expiration date and the Company’s ability to execute on the program will depend on, among other factors, cash requirements for acquisitions, cash generation from operations, debt repayment obligations, market conditions and regulatory requirements. In addition, under the Company’s senior credit agreements, the Company is subject to certain restrictions relating to its ability to repurchase shares in the event the Company’s consolidated leverage ratio exceeds certain levels, which may limit the Company’s ability to repurchase shares under this Board authorization. Through April 1, 2012, no shares have been purchased under this Board authorization.

The following table provides a reconciliation of basic to diluted weighted average shares outstanding:


	Three Months Ended
	April 1, 2012		March 27, 2011
	(Shares in thousands)
Basic		40,769		40,057
Dilutive shares assumed issued		—		367

Diluted		40,769		40,424

Weighted average stock options that were antidilutive and therefore not included in the calculation of earnings per share were approximately 8,937 thousand and 9,036 thousand for the three months ended April 1, 2012 and March 27, 2011, respectively.

The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the three months ended April 1, 2012 and March 27, 2011:


	Cash Flow Hedges			Pension and Other Postretirement Benefit Plans			Foreign Currency Translation Adjustment			Accumulated Other Comprehensive Income
	(Dollars in thousands)
Balance at December 31, 2011	$	(7,257	)	$	(134,548	)	$	(17,548	)	$	(159,353	)
Current-period other comprehensive income		2,460			978			30,605			34,043

Balance at April 1, 2012	$	(4,797	)	$	(133,570	)	$	13,057		$	(125,310	)

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


	Cash Flow Hedges			Pension and Other Postretirement Benefit Plans			Foreign Currency Translation Adjustment			Accumulated Other Comprehensive Income
	(Dollars in thousands)
Balance at December 31, 2010	$	(15,262	)	$	(95,746	)	$	59,128		$	(51,880	)
Current-period other comprehensive income		1,764			4,916			48,230			54,910
Divestiture of Marine		—			8,427			(33,424	)		(24,997	)
Discontinued operations		142			(37	)		2,072			2,177

Balance at March 27, 2011	$	(13,356	)	$	(82,440	)	$	76,006		$	(19,790	)

Note 10 — Taxes on income from continuing operations


	Three Months Ended
	April 1, 2012			March 27, 2011
Effective income tax rate		1.4	%		25.8	%

The effective income tax rate for the three months ended April 1, 2012 was 1.4% compared to 25.8% for the three months ended March 27, 2011. The Company recorded a $332 million goodwill impairment charge in the quarter for which only $45 million of the goodwill was tax deductible. Accordingly, the principal driver for the lower tax rate for the three months ended April 1, 2012 is the Company’s inability to realize the full benefit of this charge. In addition, the three months ended March 27, 2011 reflects a beneficial discrete charge for losses on extinguishments of debt during the first quarter of 2011.

Note 11 — Pension and other postretirement benefits

The Company has a number of defined benefit pension and postretirement plans covering eligible U.S. and non-U.S. employees. The defined benefit pension plans are noncontributory. The benefits under these plans are based primarily on years of service and employees’ pay near retirement. The Company’s funding policy for U.S. plans is to contribute annually, at a minimum, amounts required by applicable laws and regulations. Obligations under non-U.S. plans are systematically provided for by depositing funds with trustees or by book reserves. In 2008 the Company amended the Teleflex Retirement Income Plan (“TRIP”) to cease future benefit accruals for all employees, other than those subject to a collective bargaining agreement and amended its Supplemental Executive Retirement Plans (“SERP”) for all executives to cease future benefit accruals for both employees and executives as of December 31, 2008. The Company replaced the non-qualified defined benefits provided under the SERP with a non-qualified defined contribution arrangement under the Company’s Deferred Compensation Plan, effective January 1, 2009. In addition, in 2008, the Company’s postretirement benefit plans were amended to eliminate future benefits for employees, other than those subject to a collective bargaining agreement, who had not attained age 50 and whose age plus service was less than 65.

The Company and certain of its subsidiaries provide medical, dental and life insurance benefits to pensioners and survivors. The associated plans are unfunded and approved claims are paid from Company funds.

Net benefit cost of pension and postretirement benefit plans consisted of the following:


	Pension Three Months Ended						Other Postretirement Benefits Three Months Ended
	April 1, 2012			March 27, 2011			April 1, 2012		March 27, 2011
	(Dollars in thousands)

Service cost	$	678		$	579		$	158	$	198
Interest cost		4,126			4,244			473		550
Expected return on plan assets		(5,043	)		(4,901	)		—		—
Net amortization and deferral		1,606			1,056			123		70

Net benefit cost	$	1,367		$	978		$	754	$	818

The increase in net amortization expense for the pension and postretirement benefit plans reflects the loss in actuarial changes in benefit obligation recorded at December 31, 2011.

The Company is required to make minimum pension contributions totaling $19.5 million during 2012, of which $7.9 million were made during the three months ended April 1, 2012.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 12 — Commitments and contingent liabilities

Product warranty liability: The Company warrants to the original purchasers of certain of its products that it will, at its option, repair or replace such products, without charge, if they fail due to a manufacturing defect. Warranty periods vary by product. The Company has recourse provisions for certain products that would enable recovery from third parties for amounts paid under the warranty. The Company accrues for product warranties when, based on available information, it is probable that customers will make claims under warranties relating to products that have been sold, and a reasonable estimate of the costs (based on historical claims experience relative to sales) can be made. The following table provides information regarding changes in the Company’s product warranty liability accruals for the three months ended April 1, 2012 (dollars in thousands):


Balance – December 31, 2011	$	7,935
Accruals for warranties issued in 2012		22
Settlements (cash and in kind)		(15	)
Accruals related to pre-existing warranties (a)		(1,252	)

Balance – April 1, 2012	$	6,690

(a)	Including those related to divested businesses. See Note 15, “Divestiture-related activities” for additional information.

Operating leases: The Company uses various leased facilities and equipment in its operations. The terms for these leased assets vary depending on the lease agreement. In connection with these operating leases, the Company had residual value guarantees in the amount of approximately $1.9 million at April 1, 2012. The Company’s future payments under the operating leases cannot exceed the minimum rent obligation plus the residual value guarantee amount. The residual value guarantee amounts are based upon the unamortized lease values of the assets under lease, and are payable by the Company if the Company declines to renew the leases or to exercise its purchase option with respect to the leased assets. At April 1, 2012, the Company had no liabilities recorded for these obligations. Any residual value guarantee amounts paid to the lessor may be recovered by the Company from the sale of the assets to a third party.

Environmental: The Company is subject to contingencies as a result of environmental laws and regulations that in the future may require the Company to take further action to correct the effects on the environment of prior disposal practices or releases of chemical or petroleum substances by the Company or other parties. Much of this liability results from the U.S. Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), often referred to as Superfund, the U.S. Resource Conservation and Recovery Act (“RCRA”) and similar state laws. These laws require the Company to undertake certain investigative and remedial activities at sites where the Company conducts or once conducted operations or at sites where Company-generated waste was disposed.

Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of other potentially responsible parties. At April 1, 2012, the Company’s condensed consolidated balance sheet included an accrued liability of approximately $9.0 million relating to these matters. Considerable uncertainty exists with respect to these costs and, if adverse changes in circumstances occur, potential liability may exceed the amount accrued as of April 1, 2012. The time frame over which the accrued amounts may be paid out, based on past history, is estimated to be 15-20 years.

Litigation: The Company is a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment and environmental matters. Based on information currently available, advice of counsel, established reserves and other resources, the Company does not believe that any such actions are likely to be, individually or in the aggregate, material to its business, financial condition, results of operations or liquidity. However, litigation is subject to many uncertainties, and the outcome of litigation is not predictable with assurance. An adverse outcome in current or future litigation could have a material adverse effect on the Company’s business, financial condition, results of operations or liquidity. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred.

Tax audits and examinations: The Company and its subsidiaries are routinely subject to tax examinations by various taxing authorities. As of April 1, 2012, the most significant tax examinations in process are in Canada, Czech Republic, Germany, France and Italy. In conjunction with these examinations and as a regular and routine practice, the Company may determine a need to establish certain reserves or to adjust existing reserves with respect to uncertain tax positions. Accordingly, developments occurring with respect to these examinations, including resolution of uncertain tax positions, could result in increases or decreases to our recorded tax liabilities, which could impact our financial results.

Other: The Company has various purchase commitments for materials, supplies and items of permanent investment incident to the ordinary conduct of business. On average, such commitments are not at prices in excess of current market.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 13 — Business segment information

As a result of a reorganization of the Company’s internal business unit reporting structure and related internal financial reporting, effective January 1, 2012, the Company changed its segment reporting from a single operating segment to four operating segments.

An operating segment is a component of the Company (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the Company’s chief operating decision maker to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. Based on these criteria, the Company has identified that it has four operating segments, which also represent its four reportable segments.

Three of the four reportable segments are geographically based; North America, EMEA (representing the Company’s operations in Europe, the Middle East and Africa) and AJLA (representing the Company’s Asian and Latin American operations). The fourth reportable segment is OEM.

The Company’s geographically based segments design, manufacture and distribute medical devices primarily used in critical care, surgical applications and cardiac care and generally serve two end markets; hospitals and healthcare providers, and home health. The products of the geographically based segments are most widely used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications. The Company’s OEM Segment designs, manufactures and supplies devices and instruments for other medical device manufacturers.

The following tables present the Company’s segment results for the three months ended April 1, 2012 and March 27, 2011:


	Three Months Ended April 1, 2012
Segment Results	North America		EMEA		AJLA		OEM		Totals
	(Dollars in thousands)
Segment net revenues from external customers	$	167,308	$	134,600	$	46,988	$	38,861	$	387,757
Segment depreciation and amortization		15,313		5,149		1,250		1,617		23,329
Segment operating profit ⁽¹ ⁾		22,790		21,578		11,192		5,335		60,895
Segment assets		1,689,959		815,566		253,703		89,712		2,848,940
Segment expenditures for property, plant and equipment		3,839		2,695		7		4,900		11,441

Intersegment revenues		39,564		17,719		248		1,863


	Three Months Ended March 27, 2011
Segment Results	North America		EMEA		AJLA		OEM		Totals
	(Dollars in thousands)
Segment net revenues from external customers	$	152,724	$	125,450	$	42,033	$	33,797	$	354,004
Segment depreciation and amortization		16,431		5,282		1,316		1,612		24,641
Segment operating profit ⁽¹ ⁾		20,270		16,864		9,775		3,351		50,260
Segment assets		2,051,084		828,744		235,488		81,966		3,197,282
Segment expenditures for property, plant and equipment		3,420		1,415		49		943		5,827

Intersegment revenues		34,225		14,296		83		1,631

(1)

Segment operating profit includes a segment’s net revenues from external customers reduced by its cost of goods sold, selling, general and administrative expenses, and an allocation of corporate expenses. Segment operating profit excludes goodwill impairment charges, restructuring and impairment charges, interest income and expense, loss on extinguishment of debt and taxes on income.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following tables present reconciliations of segment results to the Company’s condensed consolidated results for the three months ended April 1, 2012 and March 27, 2011:

		0000000			0000000
Reconciliation of Segment Operating Profit to Income from Continuing Operations Before Interest, Loss on Extinguishments of Debt and Taxes	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in thousands)
Segment operating profit	$	60,895		$	50,260
Goodwill impairment		332,128			—
Restructuring and other impairment charges		(838	)		595


Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes	$	(270,395	)	$	49,665


Reconciliation of Segment Assets to Condensed Consolidated Total Assets	April 1, 2012		March 27, 2011
	(Dollars in thousands)
Segment assets	$	2,848,940	$	3,197,282
Corporate assets ⁽¹ ⁾		792,920		371,285
Assets of businesses divested ⁽² ⁾		—		101,873
Assets held for sale		8,026		8,363

Total assets	$	3,649,886	$	3,678,803

(1)	Increase in corporate assets from the prior period reflects higher cash balances as a result of sale of businesses at the end of 2011.

(2)	Includes $31.8 million of assets previously reported as assets held for sale in 2011.


Reconciliation of Segment Expenditures for Property, Plant and Equipment to Condensed Consolidated Total Expenditures for Property, Plan and Equipment	Three Months Ended
	April 1, 2012		March 27, 2011
	(Dollars in thousands)
Segment expenditures for property, plant and equipment	$	11,441	$	5,827
Corporate expenditures for property, plant and equipment		3,588		64

Total expenditures for property, plant and equipment	$	15,029	$	5,891

Note 14 — Condensed consolidated guarantor financial information

In June 2011, Teleflex Incorporated (referred to below as “Parent Company”) issued $250 million of 6.875% senior subordinated notes through a registered public offering. The notes are guaranteed, jointly and severally, by certain of the Parent Company’s subsidiaries (each, a “Guarantor Subsidiary” and collectively, the “Guarantor Subsidiaries”). The guarantees are full and unconditional, subject to certain customary release provisions. Each Guarantor Subsidiary is 100% owned by the Parent Company. The Company’s condensed consolidating statements of income and condensed consolidating statements of cash flows for the three month periods ended April 1, 2012 and March 27, 2011 and condensed consolidating balance sheets as of April 1, 2012 and December 31, 2011, each of which are set forth below, provide consolidating information for:

Parent Company, the issuer of the guaranteed obligations;

Guarantor Subsidiaries, on a combined basis;

Non-guarantor subsidiaries, on a combined basis; and

Parent Company and its subsidiaries on a consolidated basis.

The same accounting policies as described in the consolidated financial statements are used by each entity in the condensed consolidating financial information, except for the use by the Parent Company and Guarantor Subsidiaries of the equity method of accounting to reflect ownership interests in subsidiaries which are eliminated upon consolidation.

Consolidating entries and eliminations in the following consolidating financial statements represent adjustments to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor Subsidiaries and the Non-guarantor subsidiaries, (b) eliminate the investments in subsidiaries and (c) record consolidating entries.

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF INCOME


	Three Months Ended April 1, 2012
	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Condensed Consolidated
		(Dollars in thousands)
Net revenues	$	—		$	245,687		$	204,921		$	(62,851	)	$	387,757
Cost of goods sold		—			147,525			115,287			(60,890	)		201,922

Gross profit		—			98,162			89,634			(1,961	)		185,835
Selling, general and administrative expenses		15,582			63,168			34,971			(343	)		113,378
Research and development expenses		—			9,916			1,646			—			11,562
Goodwill impairment		—			331,779			349			—			332,128
Restructuring and other impairment charges		—			(1,443	)		605			—			(838	)

Income (loss) from continuing operations before interest and taxes		(15,582	)		(305,258	)		52,063			(1,618	)		(270,395	)
Interest expense		36,749			(20,451	)		1,913			—			18,211
Interest income		(125	)		(8	)		(345	)		—			(478	)

Income (loss) from continuing operations before taxes		(52,206	)		(284,799	)		50,495			(1,618	)		(288,128	)
Taxes (benefit) on income from continuing operations		(17,921	)		287			13,897			(282	)		(4,019	)
Equity in net income of consolidated subsidiaries		(250,051	)		30,996			—			219,055			—

Income (loss) from continuing operations		(284,336	)		(254,090	)		36,598			217,719			(284,109	)

Operating income from discontinued operations		946			—			—			—			946
Taxes on income from discontinued operations		345			—			—			—			345

Income from discontinued operations		601			—			—			—			601

Net income (loss)		(283,735	)		(254,090	)		36,598			217,719			(283,508	)
Less: Income from continuing operations attributable to noncontrolling interests		—			—			227			—			227

Net income (loss) attributable to common shareholders	$	(283,735	)	$	(254,090	)	$	36,371		$	217,719		$	(283,735	)

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


	Three Months Ended March 27, 2011
	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Condensed Consolidated
	(Dollars in thousands)
Net revenues	$	—		$	226,826		$	181,858		$	(54,680	)	$	354,004
Cost of goods sold		—			137,422			106,534			(54,456	)		189,500

Gross profit		—			89,404			75,324			(224	)		164,504
Selling, general and administrative expenses		9,389			59,465			33,696			656			103,206
Research and development expenses		—			9,384			1,654			—			11,038
Restructuring and other impairment charges		—			588			7			—			595

Income (loss) from continuing operations before interest, loss on extinguishments of debt and taxes		(9,389	)		19,967			39,967			(880	)		49,665
Interest expense		31,084			(15,013	)		75			—			16,146
Interest income		(2	)		(23	)		(80	)		—			(105	)
Loss on extinguishments of debt		14,597			—			—			—			14,597

Income (loss) from continuing operations before taxes		(55,068	)		35,003			39,972			(880	)		19,027
Taxes (benefit) on income from continuing operations		(19,067	)		13,861			11,475			(1,354	)		4,915
Equity in net income of consolidated subsidiaries		135,081			73,039			—			(208,120	)		—

Income from continuing operations		99,080			94,181			28,497			(207,646	)		14,112

Operating (loss) income from discontinued operations		(37,944	)		39,411			62,289			—			63,756

Taxes (benefit) on income from discontinued operations		(16,676	)		6,331			10,019			—			(326	)

Income (loss) from discontinued operations		(21,268	)		33,080			52,270			—			64,082

Net income		77,812			127,261			80,767			(207,646	)		78,194
Less: Income from continuing operations attributable to noncontrolling interests		—			—			223			—			223
Less: Income from discontinued operations attributable to noncontrolling interest		—			—			159			—			159

Net income attributable to common shareholders	$	77,812		$	127,261		$	80,385		$	(207,646	)	$	77,812

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATING BALANCE SHEETS


					April 1, 2012
	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Condensed Consolidated
	(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents	$	94,646	$	—	$	496,275	$	—		$	590,921
Accounts receivable, net		555		303,839		494,396		(487,864	)		310,926
Inventories, net		—		194,630		115,861		(11,520	)		298,971
Prepaid expenses and other current assets		7,600		4,294		25,045		—			36,939
Prepaid taxes		27,510		—		10,167		—			37,677
Deferred tax assets		7,300		26,269		6,163		(420	)		39,312
Assets held for sale		—		2,738		5,288		—			8,026

Total current assets		137,611		531,770		1,153,195		(499,804	)		1,322,772
Property, plant and equipment, net		11,460		151,221		100,734		—			263,415
Goodwill		—		670,260		449,436		—			1,119,696
Intangibles assets, net		—		702,768		168,943		—			871,711
Investments in affiliates		5,019,605		983,656		20,292		(6,021,706	)		1,847
Deferred tax assets		64,488		—		2,008		(66,204	)		292
Other assets		41,467		2,567,079		173,760		(2,712,153	)		70,153

Total assets	$	5,274,631	$	5,606,754	$	2,068,368	$	(9,299,867	)	$	3,649,886


LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	—	$	—	$	4,700	$	—		$	4,700
Accounts payable		75,815		382,174		95,283		(490,942	)		62,330
Accrued expenses		22,798		26,693		35,018		—			84,509
Payroll and benefit-related liabilities		23,690		8,280		26,397		—			58,367
Derivative liabilities		1,496		—		—		—			1,496
Accrued interest		11,612		—		6		—			11,618
Income taxes payable		—		—		27,761		—			27,761
Current liability for uncertain tax positions		—		—		23,484		—			23,484
Deferred tax liabilities		—		—		1,501		(420	)		1,081

Total current liabilities		135,411		417,147		214,150		(491,362	)		275,346
Long-term borrowings		957,360		—		—		—			957,360
Deferred tax liabilities		—		417,424		61,436		(66,204	)		412,656
Pension and other postretirement benefit liabilities		137,539		33,907		15,618		—			187,064
Noncurrent liability for uncertain tax positions		13,288		18,281		31,468		—			63,037
Other liabilities		2,311,687		183		435,352		(2,714,645	)		32,577

Total liabilities		3,555,285		886,942		758,024		(3,272,211	)		1,928,040
Total common shareholders’ equity		1,719,346		4,719,812		1,307,844		(6,027,656	)		1,719,346
Noncontrolling interest		—		—		2,500		—			2,500

Total equity		1,719,346		4,719,812		1,310,344		(6,027,656	)		1,721,846

Total liabilities and equity	$	5,274,631	$	5,606,754	$	2,068,368	$	(9,299,867	)	$	3,649,886

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


	December 31, 2011
	Parent Company		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Condensed Consolidated
	(Dollars in thousands)
ASSETS
Current assets
Cash and cash equivalents	$	114,531	$	—	$	469,557	$	—		$	584,088
Accounts receivable, net		269		304,813		464,834		(483,690	)		286,226
Inventories, net		—		201,147		107,188		(9,560	)		298,775
Prepaid expenses and other current assets		7,203		3,675		22,527		—			33,405
Prepaid taxes		24,006		—		4,869		(29	)		28,846
Deferred tax assets		8,659		26,886		5,883		(414	)		41,014
Assets held for sale		—		2,738		5,164		—			7,902

Total current assets		154,668		539,259		1,080,022		(493,693	)		1,280,256
Property, plant and equipment, net		8,208		149,300		94,404		—			251,912
Goodwill		—		1,001,353		437,189		—			1,438,542
Intangibles assets, net		—		711,962		167,825		—			879,787
Investments in affiliates		5,245,520		922,208		20,327		(6,186,047	)		2,008
Deferred tax assets		65,400		—		2,387		(67,509	)		278
Other assets		42,183		2,534,124		164,662		(2,669,649	)		71,320

Total assets	$	5,515,979	$	5,858,206	$	1,966,816	$	(9,416,898	)	$	3,924,103


LIABILITIES AND EQUITY
Current liabilities
Current borrowings	$	—	$	—	$	4,986	$	—		$	4,986
Accounts payable		101,907		387,612		64,694		(487,121	)		67,092
Accrued expenses		23,208		25,407		29,545		—			78,160
Payroll and benefit-related liabilities		24,031		13,867		26,488		—			64,386
Derivative liabilities		633		—		—		—			633
Accrued interest		10,948		—		12		—			10,960
Income taxes payable		—		—		21,113		(29	)		21,084
Current liability for uncertain tax positions		—		—		22,656		—			22,656
Deferred tax liabilities		—		—		1,465		(415	)		1,050

Total current liabilities		160,727		426,886		170,959		(487,565	)		271,007
Long-term borrowings		954,809		—		—		—			954,809
Deferred tax liabilities		—		433,078		55,264		(67,509	)		420,833
Pension and other postretirement benefit liabilities		145,533		34,034		15,417		—			194,984
Noncurrent liability for uncertain tax positions		12,678		18,437		30,573		—			61,688
Other liabilities		2,261,644		5,749		442,464		(2,671,858	)		37,999

Total liabilities		3,535,391		918,184		714,677		(3,226,932	)		1,941,320
Total common shareholders’ equity		1,980,588		4,940,022		1,249,944		(6,189,966	)		1,980,588
Noncontrolling interest		—		—		2,195		—			2,195

Total equity		1,980,588		4,940,022		1,252,139		(6,189,966	)		1,982,783

Total liabilities and equity	$	5,515,979	$	5,858,206	$	1,966,816	$	(9,416,898	)	$	3,924,103

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

TELEFLEX INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS


	Three Months Ended April 1, 2012
	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Condensed Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(44,812	)	$	72,411		$	(866	)	$	26,733


Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		(3,588	)		(7,637	)		(3,804	)		(15,029	)

Net cash used in investing activities from continuing operations		(3,588	)		(7,637	)		(3,804	)		(15,029	)


Cash Flows from Financing Activities of Continuing Operations:

Decrease in notes payable and current borrowings		—			—			(286	)		(286	)
Proceeds from stock compensation plans		1,594			—			—			1,594
Dividends		(13,866	)		—			—			(13,866	)
Intercompany transactions		43,382			(64,774	)		21,392			—

Net cash provided by (used in) financing activities from continuing operations		31,110			(64,774	)		21,106			(12,558	)

Cash Flows from Discontinued Operations:
Net cash used in operating activities		(2,595	)		—			—			(2,595	)


Net cash used in discontinued operations		(2,595	)		—			—			(2,595	)


Effect of exchange rate changes on cash and cash equivalents		—			—			10,282			10,282

Net (decrease) increase in cash and cash equivalents		(19,885	)		—			26,718			6,833
Cash and cash equivalents at the beginning of the period		114,531			—			469,557			584,088

Cash and cash equivalents at the end of the period	$	94,646		$	—		$	496,275		$	590,921

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)


	Three Months Ended March 27, 2011
	Parent Company			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Condensed Consolidated
	(Dollars in thousands)
Net cash (used in) provided by operating activities from continuing operations	$	(63,122	)	$	48,509		$	21,873		$	7,260


Cash Flows from Investing Activities of Continuing Operations:
Expenditures for property, plant and equipment		(64	)		(4,110	)		(1,717	)		(5,891	)

Proceeds from sales of businesses and assets, net of cash sold		—			62,728			38,872			101,600
Payments for businesses and intangibles acquired, net of cash acquired		—			(30,570	)		—			(30,570	)

Net cash (used in) provided by investing activities from continuing operations		(64	)		28,048			37,155			65,139


Cash Flows from Financing Activities of Continuing Operations:
Proceeds from long-term borrowings		265,000			—			—			265,000
Repayment of long-term borrowings		(330,800	)		—			—			(330,800	)
Proceeds from stock compensation plans		6,764			—			—			6,764
Dividends		(13,614	)		—			—			(13,614	)
Debt and equity issuance and amendment fees		(14,838	)		—			—			(14,838	)
Intercompany transactions		160,785			(76,557	)		(84,228	)		—

Net cash provided by (used in) financing activities from continuing operations		73,297			(76,557	)		(84,228	)		(87,488	)

Cash Flows from Discontinued Operations:
Net cash (used in) provided by operating activities		(992	)		—			2,685			1,693
Net cash used in investing activities		(3	)		—			(799	)		(802	)

Net cash (used in) provided by discontinued operations		(995	)		—			1,886			891


Effect of exchange rate changes on cash and cash equivalents		—			—			8,044			8,044

Net increase (decrease) in cash and cash equivalents		9,116			—			(15,270	)		(6,154	)
Cash and cash equivalents at the beginning of the period		22,632			—			185,820			208,452

Cash and cash equivalents at the end of the period	$	31,748		$	—		$	170,550		$	202,298

TELEFLEX INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 15 — Divestiture-related activities

When dispositions occur in the normal course of business, gains or losses on the sale of such businesses or assets are recognized in the income statement line item Net (gain) loss on sales of businesses and assets. There were no gains or losses resulting from the sale of businesses or assets that did not meet the criteria for a discontinued operation during the three month periods ending April 1, 2012 and March 27, 2011.

Discontinued Operations

During the first quarter of 2012, the Company recorded $0.9 million of income reflecting the reversal of a reserve related to the settlement of a retained liability recorded in 2011, partly offset by additional accruals in 2012.

On December 2, 2011, the Company completed the sale of its business units that design, engineer and manufacture air cargo systems and air cargo containers and pallets to a subsidiary of AAR CORP for $280.0 million in cash. The Company realized a gain of $126.8 million, net of tax, from the sale. These business units represented the sole remaining businesses in the Company’s former Aerospace Segment.

On March 22, 2011, the Company completed the sale of its marine business to an affiliate of H.I.G. Capital, LLC for $123.1 million (consisting of $101.6 million in cash, net of $1.5 million of cash included in the marine business as part of the net assets sold, plus a subordinated promissory note in the amount of $4.5 million and the assumption by the buyer of approximately $15.5 million in liabilities related to the marine business). The Company realized a gain of $57.3 million, net of tax benefits, from the sale of the business. As a result of the disposition, the Company realized accumulated losses from pension and postretirement obligations of approximately $8.4 million and cumulative translation gains of approximately $33.4 million as part of the gain on sale, resulting in a net change of approximately $25.0 million in accumulated other comprehensive income. The marine business consisted of the Company’s businesses that were engaged in the design, manufacture and distribution of steering and throttle controls and engine and drive assemblies for the recreational marine market, heaters for commercial vehicles and burner units for military field feeding appliances. The marine business represented the sole remaining business in the Company’s former Commercial Segment.

The prior period financial statements have been revised to present the cargo systems business as discontinued operations.

The following table presents the operating results of the operations that have been treated as discontinued operations for the periods presented:


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in thousands)
Net revenues	$	—		$	87,053
Costs and other expenses		(946	)		80,070
Gain on disposition		—			(56,773	)

Income from discontinued operations before income taxes		946			63,756
Provision for income taxes		345			(326	)

Income from discontinued operations	$	601		$	64,082

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

All statements made in this Quarterly Report on Form 10-Q, other than statements of historical fact, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “will,” “would,” “should,” “guidance,” “potential,” “continue,” “project,” “forecast,” “confident,” “prospects,” and similar expressions typically are used to identify forward-looking statements. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about our business and the industry and markets in which we operate. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied by these forward-looking statements due to a number of factors, including changes in business relationships with major customers or suppliers; demand for and market acceptance of new and existing products; our ability to integrate acquired businesses into our operations, realize planned synergies and operate such businesses profitably in accordance with expectations; our ability to effectively execute our restructuring programs; competitive market conditions and resulting effects on revenues and pricing; increases in raw material costs that cannot be recovered in product pricing; and global economic factors, including currency exchange rates and interest rates; difficulties entering new markets; and general economic conditions. For a further discussion of the risks relating to our business, see Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011. We expressly disclaim any obligation to update these forward-looking statements, except as otherwise specifically stated by us or as required by law or regulation.

Overview

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers in more than 130 countries through a combination of our direct sales force and distributors. Because our products are used in a wide variety of markets, we are not dependent upon any one end-market or procedure.

We categorize our products into four groups: Critical Care, Surgical Care, Cardiac Care and Original Equipment Manufacturer and Development Services (“OEM”). Critical Care, representing our largest product group, includes medical devices used in vascular access, anesthesia, urology and respiratory care applications; Surgical Care includes surgical instruments and devices; and Cardiac Care includes cardiac assist devices and equipment. OEM designs and manufactures instruments and devices for other medical device manufacturers.

Over the past several years we have focused on transitioning into a pure-play medical technology company through an extensive acquisition and divestiture program. We significantly changed the composition of our portfolio of businesses, expanding our presence in the medical technology industry, while divesting all of our businesses serving the aerospace and commercial markets, including the sale of our cargo systems and container businesses on December 2, 2011, a part of our former Aerospace Segment, and the sale of our marine business on March 22, 2011, a part of our former Commercial Segment. The cargo systems, cargo container and marine businesses are classified as discontinued operations in our 2011 condensed consolidated financial statements incorporated by reference herein.

We are focused on achieving consistent, sustainable and profitable growth by increasing our market share and improving our operating efficiencies through:

•

the development of new products and product line extensions;

•

the investment in new technologies and broadening their applications;

•

the expansion of the use of existing products in existing markets, as well as in new geographic markets;

•

leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

•

the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.

Our research and development initiatives focus on developing new, innovative products for existing and new therapeutic applications as well as enhancements to, and line extensions of, existing products. Our portfolio of existing products and pipeline of

potential new products consist primarily of Class I and Class II devices, which require 510(k) clearance by the FDA for sale in the United States. We believe the 510(k) clearance expedites the process of introducing new products and reduces our research and development costs and risks as compared to the process that would be required for Class III devices.

Change in Reporting Segments and Business Unit Structure

As discussed in our Annual Report on Form 10-K for the year ended December 31, 2011, as a result of a reorganization of our internal business unit reporting structure, effective January 1, 2012, we changed our segment reporting from a single reportable segment to four reportable segments. Three of the four reportable segments are geographically based and are presented as North America, EMEA (representing our operations in Europe, the Middle East and Africa) and AJLA (representing our Asian and Latin American operations). The fourth reportable segment is comprised of our OEM business. See Note 13 to the condensed consolidated financial statements included in this report for a discussion of the segments. In addition, in the first quarter of 2012, we changed the number of our reporting units. In 2011, we had six reporting units comprised of North America, EMEA, OEM, Japan, Asia Pacific and Latin America. In 2012, in addition to establishing a new North America segment, we established five reporting units in that segment: Vascular, Anesthesia/Respiratory, Cardiac, Surgical and Specialty. Due to the change in the reporting unit structure in North America, we were required to conduct a goodwill impairment test with respect to each of the North American reporting units in the first quarter of 2012, and determined that the goodwill of three of the reporting units was impaired. As a result, we recorded a goodwill impairment charge in the first quarter of 2012 of $332 million. See Note 4 to the condensed consolidated financial statements included in this report for a discussion of the goodwill impairment.

Health Care Reform

On March 23, 2010 the Patient Protection and Affordable Care Act was signed into law. This legislation will have a significant impact on our business. For medical device companies such as Teleflex, the expansion of medical insurance coverage should lead to greater utilization of the products we manufacture, but this legislation also contains provisions designed to contain the cost of healthcare, which could negatively affect pricing of our products. In addition, commencing in 2013, the legislation imposes a 2.3% excise tax on sales of medical devices. We continue to prepare for the implementation of this tax and to evaluate its potential impact on our business in light of several uncertainties regarding its application. As we further prepare for implementation and as the taxing authorities clarify aspects of the application of the tax relevant to us, we will be in a better position to ascertain its impact on our business. We currently estimate the impact of the medical device excise tax will be approximately $15 million annually, beginning in 2013.

Results of Operations

Discussion of constant currency excludes the impact of translating the results of international subsidiaries at different currency exchange rates from year to year.

Net Revenues

Information regarding net revenues by product group is provided in the following table.


	Three Months Ended				% Increase/ (Decrease)
	April 1, 2012		March 27, 2011		Constant Currency			Foreign Currency			Total Change
	(Dollars in millions)
Critical Care	$	256.2	$	237.1		9.5			(1.5	)		8.0
Surgical Care		72.7		65.0		13.2			(1.4	)		11.8
Cardiac Care		20.0		17.7		15.4			(2.1	)		13.3
OEM		38.9		33.8		15.4			(0.5	)		14.9
Other		—		0.4		(100.0	)		—			(100.0	)

Total net revenues	$	387.8	$	354.0		10.9			(1.4	)		9.5

Net revenues for the first quarter of 2012 increased 9.5% to $387.8 million from $354.0 million in the first quarter of 2011. The $33.8 million increase in net revenues was largely due to higher volume ($31.9 million), which benefited from six additional days in 2012 compared to 2011 and core growth, mostly in AJLA and EMEA. Net revenues further benefited from price increases across all segments and new products in North America, EMEA and OEM. These increases were partly offset by the impact of unfavorable foreign currency exchange rates in 2012.

Critical Care net revenues, excluding the impact of foreign currency exchange rates, increased 9.5% over the corresponding prior year period. The increase in net revenues was due to higher sales of anesthesia, urology, vascular access and respiratory products.

Surgical Care net revenues, excluding the impact of foreign currency exchange rates, increased 13.2% over the corresponding prior year period. The increase in net revenues was due to higher sales of ligation, general surgical instruments and closure products.

Cardiac Care net revenues, excluding the impact of foreign currency exchange rates, increased 15.4% over the corresponding prior year period. The increase in net revenues was due to higher sales of intra-aortic balloon pumps and catheters.

OEM net revenues, excluding the impact of foreign currency exchange rates, increased 15.4% over the corresponding prior year period. The increase in net revenues was due to higher sales of specialty suture and catheter fabrication products, partly offset by a decline in sales of orthopedic products.

Gross profit


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in millions)
Gross profit	$	185.8		$	164.5
Percentage of sales		47.9	%		46.5	%

For the three months ended April 1, 2012, gross profit as a percentage of revenues increased 1.4% compared to the corresponding period of 2011, primarily on price increases and lower manufacturing costs in North America, EMEA and OEM.

Selling, general and administrative


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in millions)
Selling, general and administrative	$	113.4		$	103.2
Percentage of sales		29.2	%		29.2	%

Selling, general and administrative expenses as a percentage of revenues for the first quarter of 2012 were relatively flat compared to the first quarter of 2011. The $10.2 million increase reflects higher sales and marketing costs (approximately $5 million), primarily in North America, and higher general and administrative costs (approximately $5 million) across all segments.

Research and development


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in millions)
Research and development	$	11.6		$	11.0
Percentage of sales		3.0	%		3.1	%

The increase in research and development expenses principally reflected increased investment related to vascular products in North America.

Interest expense


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in millions)
Interest expense	$	18.2		$	16.1
Average interest rate on debt		4.2	%		5.1	%

Interest expense increased in the first quarter of 2012 compared to the first quarter of 2011 due to a $37 million increase in our average outstanding debt, partly offset by lower average interest rates on debt.

Loss on extinguishments of debt

During the three months ended March 27, 2011, in connection with the prepayment of our Senior Notes issued in 2004 (the “2004 Notes”), we recognized debt extinguishment costs of approximately $14.6 million relating to the prepayment make-whole amount of $13.9 million paid to the holders of the 2004 Notes and the write-off of $0.7 million of unamortized debt issuance costs incurred prior to the prepayment of the 2004 Notes.

Taxes on income from continuing operations


	Three Months Ended
	April 1, 2012			March 27, 2011
Effective income tax rate		1.4	%		25.8	%

The effective income tax rate for the three months ended April 1, 2012 was 1.4% compared to 25.8% for the three months ended March 27, 2011. We recorded a $332 million goodwill impairment charge in the quarter for which only $45 million of the goodwill was tax deductible. Accordingly, the principal driver for the lower tax rate for the three months ending April 1, 2012 is our inability to realize the full benefit of this charge. In addition, the three months ended March 27, 2011 reflects a beneficial discrete charge for losses on extinguishments of debt during the first quarter of 2011.

Restructuring and other impairment charges


	Three Months Ended
	April 1, 2012			March 27, 2011
	(Dollars in millions)
Restructuring and other impairment charges	$	(0.8	)	$	0.6

During the three months ended April 1, 2012, we reversed approximately $2.0 million of contract termination costs related to a pending settlement of a dispute involving the termination of a European distributor agreement that was established in connection with the acquisition of Arrow in 2007. This reversal was partly offset by $1.2 million of additional termination benefit costs, facility closure costs and contract termination costs related to current restructuring activities initiated at the end of 2011 and during the first quarter of 2012.

For additional information regarding our restructuring programs, see Note 3 to our condensed consolidated financial statements included in this report.

Segment Reviews


	Three Months Ended
	April 1, 2012		March 27, 2011		% Increase
	(Dollars in millions)
North America	$	167.3	$	152.7		9.5
EMEA		134.6		125.5		7.3
AJLA		47.0		42.0		11.8
OEM		38.9		33.8		14.9

Segment net revenues	$	387.8	$	354.0		9.5

North America	$	22.8	$	20.3		12.3
EMEA		21.6		16.9		27.8
AJLA		11.2		9.8		14.3
OEM		5.3		3.3		60.6

Segment operating profit ⁽¹⁾	$	60.9	$	50.3		21.1

(1)	See Note 13 of our condensed consolidated financial statements included in this report for a reconciliation of segment operating profit to income from continuing operations before interest, loss on extinguishments of debt and taxes.

The following is a discussion of our segment operating results.

Comparison of the three months ended April 1, 2012 and March 27, 2011

North America

North America net revenues increased 9.5% in the first quarter of 2012 to $167.3 million from $152.7 million in the first quarter of 2011. The increase was due to higher volume of approximately $12.0 million, which benefited from six additional days in 2012 compared to 2011, new product sales, primarily in Vascular and Anesthesia/Respiratory, and price increases, primarily in Surgical.

North America segment operating profit increased 12.3% in the first quarter of 2012 to $22.8 million from $20.3 million in the first quarter of 2011. The increase reflects the favorable impacts from higher net revenues, partly offset by higher operating expenses, primarily in Vascular for increased sales and marketing activities, increased research and development costs in Vascular, Anesthesia/Respiratory and Surgical and an unfavorable product mix in Cardiac due to a shift in sales toward higher priced, lower margin fiber optic products.

EMEA

EMEA net revenues increased 7.3% in the first quarter of 2012 to $134.6 million from $125.5 million in the first quarter of 2011. The increase was due to higher volume of approximately $12.6 million, which benefited from six additional days in 2012 compared to 2011, new product revenues and price increases. These increases were partly offset by the unfavorable effect of foreign currency exchange rates.

EMEA segment operating profit increased 27.8% in the first quarter of 2012 to $21.6 million from $16.9 million in the first quarter of 2011. The increase reflects higher net revenues, partly offset by an increase of $1.8 million in general and administrative expenses.

AJLA

AJLA net revenues increased 11.8% in the first quarter of 2012 to $47.0 million from $42.0 million in the first quarter of 2011. The increase was due to higher volume of approximately $3.9 million, which benefited from core growth and six additional days in 2012 compared to 2011, and price increases. Approximately one-half of the core growth reflected growth in the China market. Changes in foreign currency exchange rates had a minimal impact during the quarter.

AJLA segment operating profit increased 14.3% in the first quarter of 2012 to $11.2 million from $9.8 million in the first quarter of 2011. The increase reflects the higher net revenues, partly offset by $1.4 million in inventory write-offs for excess and slow moving product and damaged product.

OEM

OEM net revenues increased 14.9% in the first quarter of 2012 to $38.9 million from $33.8 million in the first quarter of 2011. The increase was due to higher volume of approximately $3.4 million, which benefited from core growth and six additional days in 2012 compared to 2011, price increases and new products.

OEM segment operating profit increased 60.6% in the first quarter of 2012 to $5.3 million from $3.3 million in the first quarter of 2011. The increase reflects the higher net revenues, partly offset by higher manufacturing costs.

Liquidity and Capital Resources

Cash Flows

Operating activities from continuing operations provided net cash of approximately $26.7 million during the first three months of 2012 compared to $7.3 million during the first three months of 2011. The $19.4 million increase is primarily due to favorable year-over-year changes in working capital items, primarily inventory ($12.8 million) and accounts receivable ($4.4 million). The accounts receivable increase in 2011 was largely due to the termination of a factoring arrangement in Italy. The lower increase in accounts receivable in 2012 also reflects an improvement in collections in North America and most of Europe in 2012, partly offset by higher sales in 2012.

Net cash used in investing activities from continuing operations was $15.0 million during the first three months of 2012 due to capital expenditures, while investing activities from continuing operations provided net cash of $65.1 million during the first three months of 2011. In 2011, we received approximately $101.6 million in proceeds, net of $1.5 million in cash sold, from the sale of our marine business, partly offset by our acquisition of VasoNova, Inc. (“VasoNova”) for $30.6 million and capital expenditures of $5.9 million. The $30.6 million paid for the acquisition of VasoNova included the initial payment of $25 million plus a $6 million contingent payment made to the former VasoNova security holders upon receiving 510(k) clearance from the U.S. Food and Drug Administration less a hold back fee and cash in the business obtained in the acquisition. The increase in capital expenditures reflects plant expansion activities in OEM and increased investments in information technology systems.

Net cash used in financing activities from continuing operations was $12.6 million in the first three months of 2012, a decrease of approximately $74.9 million compared to the use of cash of $87.5 million during the first three months of 2011. In 2011, we used approximately $80.6 million in connection with the prepayment of our 2004 Notes (including the related make whole amounts paid to the holders of the 2004 Notes and related fees). In addition, we received lower proceeds from the exercise of outstanding stock options issued under our stock compensation plans in 2012.

Stock Repurchase Program

In 2007, our Board of Directors authorized the repurchase of up to $300 million of our outstanding common stock. Repurchases of our stock under the Board authorization may be made from time to time in the open market and may include privately-negotiated transactions as market conditions warrant and subject to regulatory considerations. The stock repurchase program has no expiration date and our ability to execute on the program will depend on, among other factors, cash requirements for acquisitions, cash generation from operations, debt repayment obligations, market conditions and regulatory requirements. In addition, under our senior credit agreements, we are subject to certain restrictions relating to our ability to repurchase shares in the event our consolidated leverage ratio exceeds certain levels, which may limit our ability to repurchase shares under this Board authorization. Through April 1, 2012, no shares have been purchased under this Board authorization.

The following table provides our net debt to total capital ratio:


	April 1, 2012			December 31, 2011
	(Dollars in millions)
Net debt includes:
Current borrowings	$	4.7		$	5.0
Long-term borrowings		957.4			954.8

Total debt		962.1			959.8
Less: Cash and cash equivalents		590.9			584.1

Net debt	$	371.2		$	375.7

Total capital includes:
Net debt	$	371.2		$	375.7
Total common shareholders’ equity		1,719.3			1,980.6

Total capital	$	2,090.5		$	2,356.3


Percent of net debt to total capital		18	%		16	%

Our senior credit agreement and the indenture under which we issued our 6.875% senior subordinated notes due 2019 contain covenants that, among other things, limit or restrict our ability, and the ability of our subsidiaries, to incur debt, create liens, consolidate, merge or dispose of certain assets, make certain investments, engage in acquisitions, pay dividends on, repurchase or make distributions in respect of capital stock and enter into swap agreements. Our senior credit agreement also requires us to maintain a consolidated leverage ratio of not more than 4.0:1 and a consolidated interest coverage ratio (generally, Consolidated EBITDA to Consolidated Interest Expense, each as defined in the senior credit agreement) of not less than 3.5:1 as of the last day of any period of four consecutive fiscal quarters calculated pursuant to the definitions and methodology set forth in the senior credit agreement. Non-recurring, non-cash charges, such as the goodwill impairment charge we recorded in the first quarter of 2012, are excluded from the calculation of these ratios and, therefore, do not affect our compliance with these covenants.

We believe that our cash flow from operations, available cash and cash equivalents and our ability to access additional funds through credit facilities will enable us to fund our operating requirements, capital expenditures and debt obligations for the next 12 months and the foreseeable future. Depending on conditions in the capital markets and other factors, we will from time to time consider other financing transactions, the proceeds of which could be used to refinance current indebtedness or for other purposes.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

See the information set forth in Part II, Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011.

Item 4.

Controls and Procedures

(a)

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report are functioning effectively to provide reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

(b)

Change in Internal Control over Financial Reporting

No change in our internal control over financial reporting occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.

Legal Proceedings

We are a party to various lawsuits and claims arising in the normal course of business. These lawsuits and claims include actions involving product liability, intellectual property, employment and environmental matters. Based on information currently available, advice of counsel, established reserves and other resources, we do not believe that any such actions are likely to be, individually or in the aggregate, material to our business, financial condition, results of operations or liquidity. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to our business, financial condition, results of operations or liquidity.

Item 1A.

Risk Factors

There have been no significant changes in risk factors for the quarter ended April 1, 2012. See the information set forth in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3.

Defaults Upon Senior Securities

Not applicable.

Item 5.

Other Information

Not applicable.

Item 6.

Exhibits

The following exhibits are filed as part of this report:


Exhibit No.		Description

10.1 —		Letter agreement, dated July 22, 2011, by and between Teleflex Incorporated and Thomas E. Powell.

10.2 —		Amendment to Teleflex Incorporated 2000 Stock Compensation Plan, effective as of January 1, 2012.

10.3 —		Amendment to Teleflex Incorporated 2008 Stock Incentive Plan, effective as of January 1, 2012.

12.1 —		Computation of ratio of earnings to fixed charges.

31.1 —		Certification of Chief Executive Officer, pursuant to Rule 13a–14(a) under the Securities Exchange Act of 1934.

31.2 —		Certification of Chief Financial Officer, pursuant to Rule 13a–14(a) under the Securities Exchange Act of 1934.

32.1 —		Certification of Chief Executive Officer, pursuant to Rule 13a–14(b) under the Securities Exchange Act of 1934.

32.2 —		Certification of Chief Financial Officer, pursuant to Rule 13a–14(b) under the Securities Exchange Act of 1934.

101.1 —		The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended April 1, 2012, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income for the three months ended April 1, 2012 and March 27, 2011; (ii) the Condensed Consolidated Statements of Comprehensive Income for the three months ended April 1, 2012 and March 27, 2011; (iii) the Condensed Consolidated Balance Sheets as of April 1, 2012 and December 31, 2011; (iv) the Condensed Consolidated Statements of Cash Flows for the three months ended April 1, 2012 and March 27, 2011; (v) the Condensed Consolidated Statements of Changes in Equity for the three months ended April 1, 2012 and March 27, 2011; and (vi) Notes to Condensed Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


TELEFLEX INCORPORATED

By:		/s/ Benson F. Smith
		Benson F. Smith Chairman, President and Chief Executive Officer (Principal Executive Officer)

By:		/s/ Thomas E. Powell
		Thomas E. Powell Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

Dated: May 1, 2012

TABLE OF CONTENTS

Part I Item 1. Financial Statements Note 1 Basis Of Presentation Note 2 New Accounting Standards Note 3 Restructuring and Other Impairment Charges Note 4 Impairment Of Goodwill Note 5 Inventories Note 6 Goodwill and Other Intangible Assets Note 7 Financial Instruments Note 8 Fair Value Measurement Note 9 Changes in Shareholders Equity Note 10 Taxes on Income From Continuing Operations Note 11 Pension and Other Postretirement Benefits Note 12 Commitments and Contingent Liabilities Note 13 Business Segment Information Note 14 Condensed Consolidated Guarantor Financial Information Note 15 Divestiture-related Activities Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II Other Information Part II Item 1. Legal Proceedings Item 1A. Risk Factors Item 2. Unregistered Sales Of Equity Securities and Use Of Proceeds Item 3. Defaults Upon Senior Securities Item 5. Other Information Item 6. Exhibits

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company